This analysis provides a useful mathematical model of the I-Wire platform, increases the number of parameters that can be derived from the device, and serves as a demonstration of quantitative characterization of nonlinear, active biomaterials.
Wide-field whole eye OCT system with demonstration of quantitative retinal curvature estimation.
McNabb, RP; Polans, J; Keller, B; Jackson-Atogi, M; James, CL; Vann, RR; Izatt, JA; Kuo, AN, Wide-field whole eye OCT system with demonstration of quantitative retinal curvature estimation., Biomedical Optics Express, vol 10 no. 1 (2019), pp. 338-355 [abs1364/BOE.10.000338] [abs].
The first set of competencies (E1) concerns demonstration of quantitative skills to data analysis.
Therefore a successful demonstration of quantitative on-resin reductive amination of salicylaldehydes, with a group capable of assisting its own acylation under standard conditions would allow automation of backbone protection installation.
In fact, for all but the traditional system, our work is the first demonstration of quantitative birefringence measurements with the specific configurations and combinations of PCCs we used, including the first with EP source light and unique systems based on CP and LP light.
DOI: http://dx.doi.org/10.7554/eLife.00378.007 10.7554/eLiFigure78.008 Figure 1 figure supplement 5. Schematic demonstrations of the quantitative measurements of vulval muscle morphology.
The evidence lies in the demonstration of a quantitative agreement between the relative abundance of the protonated, positively charged form of that group at pH's 7.25 and 8.25 (ratio 1.80) with the relative potencies (ratio 1.79) of the toxin.
To verify this hypothesis would require a demonstration of a quantitative relationship between the concentration of reducing sugars and the amount of AgNPs; however, this was beyond the scope of the present study.
This finding is based on the demonstration of (1) quantitative differences in circulating EMVs in various animal disease models; (2) changes in circulating EMV levels occurring prior to the onset of atherosclerotic or diabetic symptoms; and (3) differential modulation of the EMV signature in course of pharmacological interference.
